Markus Seeliger

22PUBLICATIONS
78CO-AUTHORS
Biomolecular modelling and designMolecular targetsPharmaceutical delivery technologiesChemical and thermal processes in energy and combustionCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 23, 2026
A design approach for bitopic kinase inhibitors.

|Mar 10, 2025
Prospective evaluation of structure-based simulations reveal their ability to predict the impact of kinase mutations on inhibitor binding.

Sukrit Singh, Vytautas Gapsys, Matteo Aldeghi

|Mar 07, 2025
Prospective Evaluation of Structure-Based Simulations Reveal Their Ability to Predict the Impact of Kinase Mutations on Inhibitor Binding.

Sukrit Singh, Vytautas Gapsys, Matteo Aldeghi

|Jul 11, 2024
Calculating Protein-Ligand Residence Times through State Predictive Information Bottleneck Based Enhanced Sampling.

Suemin Lee, Dedi Wang, Markus A Seeliger

|Jul 04, 2024
SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis.

Surbhi Chouhan, Dhivya Sridaran, Cody Weimholt

|Jan 31, 2024
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo.

Daniel P Radin, Sophie Shifman, Ian R Outhwaite

Pageof 4

Frequent Collaborators

7 joint publications

Ian R Outhwaite

6 joint publications

Aziz M Rangwala

3 joint publications

Sukrit Singh

3 joint publications

Stefan Knapp